Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COVID-19-Associated Acute Respiratory Distress Syndrome (ARDS)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05077319
What this trial is testing

Characteristics and Outcome of Patients With COVID-19 in ICUs in South Tyrol

Who this might be right for
COVID-19COVID-19 Acute Respiratory Distress Syndrome
Institute of Mountain Emergency Medicine 550
Not applicableStudy completedNCT05394961
What this trial is testing

Factors Associated With Decisions to Withhold or Withdraw Intensive Care

Who this might be right for
SepsisARDS, HumanCOVID-19
Uppsala University 33,256
Not applicableStudy completedNCT05092737
What this trial is testing

Physiological Response to Prone Position in COVID-19 Associated Acute Respiratory Distress Syndrome (ARDS)

Who this might be right for
ARDSSars-CoV-2 Infection
University of Lausanne Hospitals 31
Early research (Phase 1)UnknownNCT04525378
What this trial is testing

MSC-based Therapy in COVID-19-associated Acute Respiratory Distress Syndrome

Who this might be right for
Covid19ARDS, Human
D'Or Institute for Research and Education 20
Testing effectiveness (Phase 2)Study completedNCT04389671
What this trial is testing

The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)

Who this might be right for
COVID-19Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)
Windtree Therapeutics 20
Early research (Phase 1)Ended earlyNCT05027815
What this trial is testing

Tregs for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Associated With COVID-19 (regARDS)

Who this might be right for
Acute Respiratory Distress Syndrome Due to Disease Caused by 2019-nCoV
Jeffrey Bluestone 7
Large-scale testing (Phase 3)Ended earlyNCT04750278
What this trial is testing

Evaluate FP-025 in Patients With Severe to Critical COVID 19

Who this might be right for
Severe to Critical COVID 19 With Associated ARDS
Foresee Pharmaceuticals Co., Ltd. 90
Testing effectiveness (Phase 2)Ended earlyNCT04922957
What this trial is testing

A Phase 2b Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19 With Associated Acute Respiratory Distress Syndrome (ARDS)

Who this might be right for
Covid19
Enlivex Therapeutics Ltd. 12
Not applicableStudy completedNCT05080933
What this trial is testing

ECMO for COVID-19 vs Influenza A H1N1 Associated ARDS

Who this might be right for
ARDSCOVID-19H1N1 Influenza
University of Turin, Italy 308
Not applicableStudy completedNCT04351906
What this trial is testing

Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome

Who this might be right for
ARDSHypercapnic Respiratory FailureAKI
University of Giessen 20
Not applicableStudy completedNCT04343404
What this trial is testing

Place of ECMO in the Management of Severe Refractory ARDS Associated With Covid-19

Who this might be right for
Respiratory Distress Syndrome
University Hospital, Strasbourg, France 100
Testing effectiveness (Phase 2)Ended earlyNCT04441385
What this trial is testing

Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19).

Who this might be right for
COVID-19
Hospital Universitario Infanta Leonor 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT04565665
What this trial is testing

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

Who this might be right for
COVID-19 InfectionCOVID-19-Associated Acute Respiratory Distress SyndromeHematopoietic and Lymphoid Cell Neoplasm+2 more
M.D. Anderson Cancer Center 65
Not applicableStudy completedNCT05076240
What this trial is testing

FilmArray® and Management of Ventilator Associated Pneumonia in COVID-19 ARDS

Who this might be right for
SARS-CoV2 InfectionVentilator Associated PneumoniaArds+1 more
Centre Hospitalier Universitaire de Nīmes 98
Large-scale testing (Phase 3)Ended earlyNCT04327401
What this trial is testing

COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III

Who this might be right for
Coronavirus InfectionPneumonia, ViralAcute Respiratory Distress Syndrome
Hospital Sirio-Libanes 299
Not applicableNo Longer AvailableNCT04366830
What this trial is testing

Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection

Who this might be right for
Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19
Mesoblast International Sàrl
Testing effectiveness (Phase 2)UnknownNCT05258682
What this trial is testing

Safety of Nebulized Combination Therapy BromAc® in COVID-19 Respiratory Disease

Who this might be right for
COVID-19 PneumoniaCOVID-19Ventilator Associated Pneumonia+1 more
Mucpharm Pty Ltd 30
Not applicableStudy completedNCT05699889
What this trial is testing

Acute Kidney Dysfunction in COVID-19 and Non-COVID-19 Related ARDS

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeAcute Kidney Injury Due to COVID-19
Assistance Publique Hopitaux De Marseille 130
Not applicableStudy completedNCT04446286
What this trial is testing

Bicentric Study on the Use of ECMO-VV or VA for Severe ARDS Associated With Covid-19

Who this might be right for
Covid-19
University Hospital, Strasbourg, France 50
Large-scale testing (Phase 3)Study completedNCT06729606
What this trial is testing

Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

Who this might be right for
Covid19
National Institute of Allergy and Infectious Diseases (NIAID) 471
Next Page